EMEA-001674-PIP01-14 - paediatric investigation plan

lutetium (177Lu) chloride

Key facts

• Active substance:
  lutetium (177Lu) chloride
• Therapeutic area:
  Oncology
• Decision number:
  P/0029/2015
• PIP number:
  EMEA-001674-PIP01-14
• Pharmaceutical form(s):
  • Radiopharmaceutical precursor
  • Solution
• Condition(s) / indication(s):
  Radiolabelling agent
• Route(s) of administration:
  Intravenous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  30/01/2015
• Compliance check done:
  No

Decision

P/0029/2015: EMA decision of 30 January 2015 on the granting of a product specific waiver for lutetium [177 Lu] (chloride) (EMEA-001674-PIP01-14)

Adopted Reference Number: EMA/792665/2014